Control of haematological cancers by Natural Killer cells

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1107417

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Haematological cancers affect the blood and lymphoid organs and are generally lethal. Therapies targeting the anti-tumour capacities of the immune system have shown promising results in cancer patients. Natural Killer (NK) cells are key players of anti-tumour immune responses. This project will provide a better understanding of NK cell-mediated control of haematological malignancies that will be directly applied to the design of new curative therapies for blood cancer patients.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $314,644.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Tumour Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

immune evasion | immune suppression | immune surveillance | immunotherapy | multiple myeloma

Related Links